Jury Finds Monsanto Manipulated Scientific Data

A jury determined that Monsanto acted with malice and disregarded cancer risks associated with glyphosate. The court found the company intended to mislead consumers regarding the potential health risks of Roundup. Some scientists suggest the chemical likely causes cancer, while others disagree. Verdicts in glyphosate cases remain split, with approximately half of juries siding with plaintiffs and the other half with the manufacturer. Court proceedings revealed that juries are split nearly 50/50 on glyphosate-related verdicts. The company is accused of orchestrating the publication of non-legitimate research in peer-reviewed journals to influence public perception. This move was intended to protect the company's bottom line by pushing misinformation to muddy scientific consensus. The ruling follows investigations into the company's efforts to persuade regulators of product safety despite conflicting evidence. This action is described as an attempt to poison the well of scientific debate. This finding challenges the integrity of previous studies used to support the product's safety profile. Critics argue that the manipulation of scientific literature undermines the integrity of scientific debate and public trust in product safety. The findings suggest that some scientists received payments ranging from $1,000 to $5,000 to influence research outcomes.